Multi-pathway targeted therapy of MASH-HCC using miR-22
Abstract Background The treatment options for hepatocellular carcinoma (HCC) are limited, and there is no effective drug that can improve long-term survival rates. Complicated cocktails consisting of multiple medications with toxicities are frequently used to treat cancer. The current study addresse...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-02-01
|
| Edice: | Cell & Bioscience |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13578-025-01352-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|